Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Report by: Rick Body, Specialist Registrar in Emergency Medicine
Search checked by: Martin Newbury, Senior Clinical Fellow in Emergency Medicine
Institution: Hope Hospital, Salford, UK
A short-cut review was carried out to establish whether the measurement of plasma heart fatty acid binding protein at the time of presentation is of any help in the accurate early diagnosis of acute myocardial infarction (AMI). Six papers presented evidence addressing the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are shown in table 1. The clinical bottom line is that although heart fatty acid binding protein is a promising biomarker it cannot be used alone to rule out the diagnosis of AMI.
In [patients who present to the emergency department with chest pain and have a suspected acute coronary syndrome] does [measurement of plasma heart fatty acid binding protein at the time of presentation] enable [accurate early diagnosis of acute myocardial infarction]?
A 35-year-old man presents to the emergency department (ED) 15 minutes after having experienced 30 minutes …